FIRST IN HUMAN PHASE 1 DOSE ESCALATION AND EXPANSION CLINICAL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS AND ANTITUMOR ACTIVITY OF INTRAVENOUS AROG4-01 IN PATIENTS WITH ADVANCED SOLID TUMORS.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517569-18-00

Acronym

AROG4-01-01

Enrollment

Registered

2025-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with advanced refractory solid tumors.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026